• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估致幻蘑菇辅助心理疗法在弱势群体中的特殊考虑因素。

Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.

机构信息

Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, USA; Department of Psychology, University of Alabama at Birmingham, USA.

Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, USA.

出版信息

Neuropharmacology. 2022 Aug 15;214:109127. doi: 10.1016/j.neuropharm.2022.109127. Epub 2022 May 13.

DOI:10.1016/j.neuropharm.2022.109127
PMID:35577136
Abstract

Psilocybin-facilitated psychotherapy shows potential transdiagnostic efficacy for a range of mental health conditions. Though vulnerable populations bear disproportionate mental health burden, they have been largely neglected in the clinical psilocybin literature. However, if the field is to best respond to the diverse needs of individuals from vulnerable populations, care must be taken to ensure these individuals are represented in the empirical research. This report calls attention to this concern by detailing the challenges and opportunities associated with evaluating psilocybin-facilitated psychotherapy in vulnerable populations. First, we show how working with vulnerable populations must be considered in the context of an often-problematic past and differential exposure to and experience with classic psychedelics. We then provide actionable recommendations for future research testing psilocybin-facilitated psychotherapy in vulnerable populations, including an emphasis on recruitment strategies, the appropriate communication and assessment of subjective effects, building therapeutic alliance, multicultural competence, and flexible study designs. On these premises we call for future work in this area, underscoring that there is vast room for improvement and expansion in this rapidly advancing field of study.

摘要

迷幻蘑菇辅助心理治疗对一系列心理健康状况显示出潜在的跨诊断疗效。尽管弱势群体承受着不成比例的精神健康负担,但他们在迷幻蘑菇的临床文献中基本上被忽视了。然而,如果该领域要最好地满足弱势群体个体的多样化需求,就必须注意确保这些个体在实证研究中得到代表。本报告通过详细说明在弱势群体中评估迷幻蘑菇辅助心理治疗相关的挑战和机遇,提请人们注意这一问题。首先,我们展示了在一个常常存在问题的过去的背景下,以及在接触和体验经典迷幻剂方面的差异,必须考虑到与弱势群体合作的问题。然后,我们为未来在弱势群体中测试迷幻蘑菇辅助心理治疗的研究提供了切实可行的建议,包括强调招募策略、适当的沟通和主观效果评估、建立治疗联盟、多元文化能力和灵活的研究设计。在此基础上,我们呼吁在这一领域开展未来的工作,强调在这个快速发展的研究领域有很大的改进和拓展空间。

相似文献

1
Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.评估致幻蘑菇辅助心理疗法在弱势群体中的特殊考虑因素。
Neuropharmacology. 2022 Aug 15;214:109127. doi: 10.1016/j.neuropharm.2022.109127. Epub 2022 May 13.
2
The emerging role of psilocybin and MDMA in the treatment of mental illness.迷幻蘑菇和 MDMA 在精神疾病治疗中的新兴作用。
Expert Rev Neurother. 2020 Dec;20(12):1263-1273. doi: 10.1080/14737175.2020.1826931. Epub 2020 Sep 30.
3
Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.迷幻蘑菇辅助心理疗法治疗抑郁症:一种具有丰富历史的迷幻化合物的新兴研究。
J Neurol Sci. 2022 Mar 15;434:120096. doi: 10.1016/j.jns.2021.120096. Epub 2021 Dec 16.
4
The Therapeutic Potential of Psilocybin.迷幻蘑菇的治疗潜力。
Molecules. 2021 May 15;26(10):2948. doi: 10.3390/molecules26102948.
5
[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].[辅助使用血清素能精神活性物质的心理治疗:可能性与挑战]
Fortschr Neurol Psychiatr. 2017 Jul;85(7):383-392. doi: 10.1055/s-0043-103085. Epub 2017 Aug 2.
6
Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy.在迷幻辅助心理治疗不断发展的法律环境下的安全考虑因素。
Subst Abuse Treat Prev Policy. 2022 May 14;17(1):37. doi: 10.1186/s13011-022-00468-0.
7
Psilocybin occasioned mystical-type experiences.裸盖菇素引发了神秘主义类型的体验。
Hum Psychopharmacol. 2020 Sep;35(5):e2742. doi: 10.1002/hup.2742. Epub 2020 Jun 23.
8
Psilocybin for Trauma-Related Disorders.迷幻蘑菇素治疗创伤相关障碍。
Curr Top Behav Neurosci. 2022;56:319-332. doi: 10.1007/7854_2022_366.
9
Compassionate use of psychedelics.同情用药的致幻剂。
Med Health Care Philos. 2020 Sep;23(3):485-496. doi: 10.1007/s11019-020-09958-z.
10
Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?迷幻蘑菇辅助心理治疗治疗难治性抑郁症:哪种心理治疗?
Int J Ment Health Nurs. 2023 Dec;32(6):1766-1772. doi: 10.1111/inm.13214. Epub 2023 Aug 17.

引用本文的文献

1
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.裸盖菇素试验中使用的研究材料的全领域综述与分析:二十年研究评估
Psychedelic Med (New Rochelle). 2025 Feb 27;3(1):1-18. doi: 10.1089/psymed.2024.0019. eCollection 2025 Mar.
2
Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.裸盖菇素治疗抑郁症随机对照试验的增量疗效系统评价与荟萃分析
Psychopharmacology (Berl). 2025 Apr 23. doi: 10.1007/s00213-025-06788-w.
3
Psychedelic-Assisted Therapy Training: An Argument in Support of Firsthand Experience of Nonordinary States of Consciousness in the Development of Competence.
迷幻辅助疗法培训:支持在能力发展中亲身经历非寻常意识状态的观点。
Psychedelic Med (New Rochelle). 2024 Sep 4;2(3):130-137. doi: 10.1089/psymed.2023.0004. eCollection 2024 Sep.
4
The Elephant in the Room: Personal Use of Psychedelics Among Psychedelic Researchers.显而易见的问题:迷幻药研究人员中迷幻药的个人使用情况
Psychedelic Med (New Rochelle). 2023 Sep 13;1(3):122-123. doi: 10.1089/psymed.2023.29002.psh. eCollection 2023 Sep.
5
The library is open: a scoping review on queer representation in psychedelic research.图书馆开放:关于迷幻药研究中酷儿群体代表性的范围综述。
Front Public Health. 2024 Dec 11;12:1472559. doi: 10.3389/fpubh.2024.1472559. eCollection 2024.
6
Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.摇头丸和迷幻剂辅助心理治疗对青少年抑郁症和创伤的治疗潜力。
Curr Psychiatry Rep. 2025 Feb;27(2):88-97. doi: 10.1007/s11920-024-01577-2. Epub 2024 Dec 19.
7
Practical considerations in the establishment of psychedelic research programs.建立迷幻剂研究项目的实际考量
Psychopharmacology (Berl). 2025 Jan;242(1):27-43. doi: 10.1007/s00213-024-06722-6. Epub 2024 Dec 4.
8
Psilocybin for the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的裸盖菇素
Front Neurosci. 2024 Jul 10;18:1420601. doi: 10.3389/fnins.2024.1420601. eCollection 2024.
9
Psychedelic Microdosing among Young Adults from Southern California.南加州年轻人中的迷幻药微剂量服用情况。
J Psychoactive Drugs. 2024 Feb 10:1-12. doi: 10.1080/02791072.2024.2313684.
10
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.LSD 和迷幻蘑菇自我治疗的调查:来自 2020 年全球毒品调查的结果。
J Psychopharmacol. 2023 Jul;37(7):733-748. doi: 10.1177/02698811231158245. Epub 2023 Mar 6.